News

• 2019.07.24 Information

  Announcing a strategic capital alliance and comprehensive partnership agreement with Tupac.Bio

  Synplogen has entered into a strategic capital alliance and comprehensive partnership agreement with Tupac.bio, a developer of bioinformatics tools, to develop new software for accelerating the bioindustry.
  Click here for details.

• 2019.06.23 Information

  Featured in The Nikkei

  Synplogen’s business was featured in the June 23 morning edition of The Nikkei
  Click here for details.

• 2019.06.01 Information

  Presented at “The Rise of Life Science Ecosystem”

  Synplogen scientist David Lips introduced the business at “The Rise of Life Science Ecosystem,” a Kobe-Bayer joint event held in Boston, USA.

• 2019.05.28 News Release

  Raised 1 billion yen through third party allotment

  Through a third-party allotment of new shares to JAFCO Co., Ltd., Synplogen raised a total of 1 billion yen. This funding will be used to launch a cutting-edge commercial production facility for long-chain synthetic DNA, as well as for in-house research and development endeavors.
  Click here for details.

• 2019.05.28 News Release

  Signed a license agreement for DNA synthesis technology with Kobe University et al.

  Synplogen, Kobe University and the New Energy and Industrial Technology Development Organization (NEDO) have signed a contract to license to Synplogen DNA synthesis technology developed within Kobe University. The technology was developed by Synplogen director Dr. Kenji Tsuge with the support of NEDO.
  Click here for details.

• 2019.05.09 Information

  Presented at Global Biofoundry Meeting 2019

  Synplogen scientist David Lips introduced the business to many leading researchers in the field of synthetic biology at “Global Biofoundry Meeting 2019.”

• 2018.11.17 Information

  Featured in Kobe Shimbun

  An introduction of our business was published in the November 18 edition of Kobe Shimbun.
  Click here for details.

• 2018.10.09 News Release

  Raised 100 million yen through third party allotment

  A total of ¥ 100 million was raised through a third-party allotment of new shares from Spiber Inc. Synplogen expects this strategic partnership to accelerate its R&D and business development endeavors.
  Click here for details.

• 2017.07.14 News Release

  Publication in the 26th presidential regular press conference release of Kobe University National University Corporation

  The establishment of Synplogen Co., Ltd. and future business vision was announced in the 26th presidential regular press conference release of Kobe University National University Corporation.
  Click here for details.